Analyst Update: Regeneron Pharmaceuticals Inc, Scotts Miracle-Gro Co, and Metlife Inc

Analysts revised their ratings and price targets on Regeneron Pharmaceuticals Inc (REGN), Scotts Miracle-Gro Co (SMG), and Metlife Inc (MET)

Aug 4, 2016 at 3:05 PM
facebook X logo linkedin

Analysts are weighing in on biotech stock Regeneron Pharmaceuticals Inc (NASDAQ:REGN), lawn care specialist Scotts Miracle-Gro Co (NYSE:SMG), and insurance issue Metlife Inc (NYSE:MET)Here's a quick roundup of today's brokerage notes on REGN, SMG, and MET.  

  • REGN posted weaker-than-expected second-quarter revenue, as well as its slowest sales growth in eight quarters. The stock is down 2.6% at $429.70 today, even after Jefferies and Piper Jaffray both raised their price targets on the stock, to $436 and $447, respectively. Regeneron Pharmaceuticals Inc has rocketed more than 20% higher in the past month, and just yesterday topped its 200-day moving average for the first time in 2016. Options traders have maintained an upbeat outlook on the stock, which has historically outperformed in the second half. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), REGN's 10-day call/put volume ratio of 2.09 sits higher than 88% of the past year's readings.
  • SMG is 2% higher at $79.56 -- fresh off a record high of $80.14 -- extending yesterday's rally, which stemmed from a fiscal third-quarter earnings beat and a Zika-related lift for insecticide makers. J.P. Morgan Securities today awarded an upgrade to "overweight" from "neutral," and a price-target hike to $85 from $70 -- representing never-before-seen territory for the shares. Year-over-year, Scotts Miracle-Gro Co has already added 22%, but the stock could stand to benefit further from a unwinding of bearish sentiment. Among the seven brokerage firms following SMG, only two recommend buying the shares, leaving the door wide open for future upgrades. Plus, short interest on the equity has been creeping higher, climbing nearly 22% during the two most recent reporting periods.
  • MET's second-quarter earnings fell short of expectations, with post-"Brexit" low interest rates weighing on profits, leading RBC to cut its price target on the stock to $53 from $56. The shares have sunk 9.5% to $39.20 as a result -- marking the fifth straight post-earnings drop -- but more negative analyst attention could easily come MET's way. At the moment, 73% of the brokerages tracking the stock maintain a "buy" or better rating, without a "sell" on the books. More evidence that downgrades may be overdue: Metlife Inc's 29% year-over-year decline, with its 200-day moving average pressuring the shares lower since last August.
Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI